Comment
|
After transfection into 293 cells AKT1 was activated 20- and 50-fold in response to insulin and IGF-1 respectively.
|
Formal Description Interaction-ID: 389
|
|
Drugbank entries
|
Show/Hide entries for
AKT1
|
Drugbank
DB00171
|
|
Drugbank
DB01169
|
|
Drugbank
DB01863
|
Inositol 1,3,4,5-Tetrakisphosphate
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB00171
|
|
Drugbank
DB01863
|
Inositol 1,3,4,5-Tetrakisphosphate
|
|
|
Comment
|
After transfection into 293 cells AKT1 was activated 20- and 50-fold in response to insulin and IGF-1 respectively.
|
Formal Description Interaction-ID: 391
|
|
Drugbank entries
|
Show/Hide entries for
IGF1
or
AKT1
|
Drugbank
DB01890
|
|
Drugbank
DB02643
|
N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propa ...
|
Drugbank
DB01890
|
|
Drugbank
DB00171
|
|
Drugbank
DB01169
|
|
Drugbank
DB01863
|
Inositol 1,3,4,5-Tetrakisphosphate
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB00171
|
|
Drugbank
DB01863
|
Inositol 1,3,4,5-Tetrakisphosphate
|
|
|
Comment
|
The activation of AKT1 was accompanied by its phosphorylation at Thr308 and Ser473 and, like activation, phosphorylation
of both of these residues was prevented by the phosphatidylinositol 3-kinase inhibitor wortmannin.
|
Formal Description Interaction-ID: 393
|
increases_phosphorylation of
at Thr308 and Ser473
|
Drugbank entries
|
Show/Hide entries for
AKT1
|
Drugbank
DB00171
|
|
Drugbank
DB01169
|
|
Drugbank
DB01863
|
Inositol 1,3,4,5-Tetrakisphosphate
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB00171
|
|
Drugbank
DB01863
|
Inositol 1,3,4,5-Tetrakisphosphate
|
|
|
Comment
|
The activation of AKT1 was accompanied by its phosphorylation at Thr308 and Ser473 and, like activation, phosphorylation of both of these residues was prevented by the phosphatidylinositol 3-kinase inhibitor wortmannin.
|
Formal Description Interaction-ID: 394
|
affects_phosphorylation of
at Thr308 and Ser473
|
Drugbank entries
|
Show/Hide entries for
IGF1
or
AKT1
|
Drugbank
DB01890
|
|
Drugbank
DB02643
|
N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propa ...
|
Drugbank
DB01890
|
|
Drugbank
DB00171
|
|
Drugbank
DB01169
|
|
Drugbank
DB01863
|
Inositol 1,3,4,5-Tetrakisphosphate
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB00171
|
|
Drugbank
DB01863
|
Inositol 1,3,4,5-Tetrakisphosphate
|
|
|
Comment
|
Wortmannin is a phosphatidylinositol 3-kinase inhibitor.
|
Formal Description Interaction-ID: 397
|
decreases_phosphorylation of
at Thr308 and Ser473
|
Drugbank entries
|
Show/Hide entries for
AKT1
|
Drugbank
DB00171
|
|
Drugbank
DB01169
|
|
Drugbank
DB01863
|
Inositol 1,3,4,5-Tetrakisphosphate
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB00171
|
|
Drugbank
DB01863
|
Inositol 1,3,4,5-Tetrakisphosphate
|
|
|
Comment
|
MAPKAP kinase-2 phosphorylates Ser473 of AKT1 causing partial activation.
|
Formal Description Interaction-ID: 401
|
increases_phosphorylation of
at Ser473
|
Drugbank entries
|
Show/Hide entries for
MAPKAPK2
or
AKT1
|
Drugbank
DB02010
|
|
Drugbank
DB03431
|
|
Drugbank
DB07234
|
3-{[(1R)-1-phenylethyl]amino}-4-(pyridin ...
|
Drugbank
DB07406
|
(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMIN ...
|
Drugbank
DB07430
|
(10R)-10-methyl-3-(6-methylpyridin-3-yl) ...
|
Drugbank
DB07431
|
(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-t ...
|
Drugbank
DB07728
|
2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6 ...
|
Drugbank
DB08358
|
2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7- ...
|
Drugbank
DB02010
|
|
Drugbank
DB03431
|
|
Drugbank
DB00171
|
|
Drugbank
DB01169
|
|
Drugbank
DB01863
|
Inositol 1,3,4,5-Tetrakisphosphate
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB00171
|
|
Drugbank
DB01863
|
Inositol 1,3,4,5-Tetrakisphosphate
|
|
|
Comment
|
MAPKAP kinase-2 phosphorylates Ser473 of AKT1 causing partial activation.
|
Formal Description Interaction-ID: 404
|
by phosphorylation at Ser473
|
Drugbank entries
|
Show/Hide entries for
MAPKAPK2
or
AKT1
|
Drugbank
DB02010
|
|
Drugbank
DB03431
|
|
Drugbank
DB07234
|
3-{[(1R)-1-phenylethyl]amino}-4-(pyridin ...
|
Drugbank
DB07406
|
(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMIN ...
|
Drugbank
DB07430
|
(10R)-10-methyl-3-(6-methylpyridin-3-yl) ...
|
Drugbank
DB07431
|
(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-t ...
|
Drugbank
DB07728
|
2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6 ...
|
Drugbank
DB08358
|
2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7- ...
|
Drugbank
DB02010
|
|
Drugbank
DB03431
|
|
Drugbank
DB00171
|
|
Drugbank
DB01169
|
|
Drugbank
DB01863
|
Inositol 1,3,4,5-Tetrakisphosphate
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB00171
|
|
Drugbank
DB01863
|
Inositol 1,3,4,5-Tetrakisphosphate
|
|
|